Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pain and Therapy
Published in: Pain and Therapy 2/2020

Open Access 01-12-2020 | Migraine | Commentary

“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies

Author: Paolo Martelletti

Published in: Pain and Therapy | Issue 2/2020

Login to get access

Excerpt

Chronic migraine is a neurological disorder associated with a highly disabling and burdensome form of pain.
The management of chronic migraine must be allocated to the appropriate healthcare professionals.
Monoclonal antibodies against CGRP(r) should initially be reserved for the treatment of patients with pre-chronic migraine in order to reduce the economic impact to healthcare systems.
…
Literature
1.
Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19:17.CrossRefPubMedPubMedCentral
2.
Yao C, Wang Y, Wang L, et al. Burden of headache disorders in China, 1990–2017: findings from the global burden of disease study 2017. J Headache Pain. 2019;20:102.CrossRefPubMedPubMedCentral
3.
Hester RB, Rohrer SD, Liu PI, Coggin JH Jr. Prevalence and burden of headache in children and adolescents in Austria—A nationwide study in a representative sample of pupils aged 10–18 years. J Headache Pain. 2019;20:101.CrossRef
4.
Martelletti P, Schwedt TJ, Lanteri-Minet M, et al. My migraine voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain. 2018;19:115.CrossRefPubMedPubMedCentral
5.
Martelletti P. Migraine disability complicated by medication overuse. Eur J Neurol. 2018;25:1193–4.CrossRefPubMed
6.
Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020;24:19.CrossRefPubMed
7.
8.
Negro A, Sciattella P, Rossi D, Guglielmetti M, Martelletti P, Mennini FS. Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre. J Headache Pain. 2019;20:120.CrossRefPubMedPubMedCentral
9.
Giamberardino MA, Affaitati G, Costantini R, Guglielmetti M, Martelletti P. Acute headache management in emergency department. A narrative review. Intern Emerg Med. 2020;15:109–17.CrossRefPubMed
10.
Sipilä JOT, Ruuskanen JO, Rautava P, Kytö V. Adult migraine hospital admission trends in Finland: a nationwide registry study. J Clin Med. 2020;9:E320.CrossRefPubMed
11.
Doretti A, Shestaritc I, Ungaro D, Lee JI, et al. Headaches in the emergency department—a survey of patients' characteristics facts and needs. J Headache Pain. 2019;20:100.CrossRefPubMedPubMedCentral
12.
Peres MFP, Swerts DB, de Oliveira AB, Silva-Neto RP. Migraine patients' journey until a tertiary headache center: an observational study. J Headache Pain. 2019;20:88.CrossRefPubMedPubMedCentral
13.
Steiner TJ, Jensen R, Katsarava Z, Linde M, et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019;20:57.CrossRefPubMedPubMedCentral
14.
15.
Urits I, Jones MR, Gress K, et al. CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep. 2019;23:29.CrossRefPubMed
16.
Sacco S, Bendtsen L, Ashina M, et al. European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019;20:6.CrossRefPubMedPubMedCentral
17.
Martelletti P. The application of CGRP(r) monoclonal antibodies in migraine spectrum: needs and priorities. BioDrugs. 2017;31:483–5.CrossRefPubMed
18.
Serrano D, Lipton RB, Scher AI, et al. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain. 2017;18:101.CrossRefPubMedPubMedCentral
19.
Guglielmetti M, Raggi A, Ornello R, et al. The clinical and public health implications and risks of widening the definition of chronic migraine. Cephalalgia. 2020;40(4):407–10.CrossRefPubMed
20.
Martelletti P, Edvinsson L, Ashina M. Shaping the future of migraine targeting calcitonin-gene-related-peptide with the disease-modifying migraine drugs (DMMDs). J Headache Pain. 2019;20:60.CrossRefPubMedPubMedCentral
Metadata
Title
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Author
Paolo Martelletti
Publication date
01-12-2020
Publisher
Springer Healthcare
Keywords
Migraine
Headache
Published in
Pain and Therapy / Issue 2/2020
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-020-00171-7

Other articles of this Issue 2/2020

Pain and Therapy 2/2020 Go to the issue

Letter

Letter to the Editor Regarding Efficacy and Safety of Diclofenac and Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study

Original Research

Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial

Case Report

Successful Treatment of Refractory Cancer Pain and Depression with Continuous Intrathecal Administration of Dexmedetomidine and Morphine: A Case Report

Original Research

Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study

Review

Clinical Efficacy and Safety Profile of Topical Etofenamate in the Treatment of Patients with Musculoskeletal Disorders: A Systematic Review

Original Research

Comparison Between Intravenous Nalbuphine and Lidocaine in Reducing Propofol-Induced Injection Pain During Gastroscopy: A Randomized Controlled Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits